stable angina core curric.ppt - university of alberta · 2020. 4. 17. · stable angina stable cad...
TRANSCRIPT
![Page 1: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/1.jpg)
Stable AnginaStable CAD
Gábor Gyenes Core Curriculum Talk
October 7, 2011
![Page 2: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/2.jpg)
Disclosure of Conflicts of Interest
I have received travel grants and honoraria from sanofi-aventis, Pfizer, Servier, Merck, Procter & Gamble, Biovail, AstraZeneca,
Medtronic, Novartis, Boehringer-Ingelheim and Merck/Frosst/Schering
I was the Primary Investigator of studies sponsored by Pfizer, Boehringer-
Ingelheim, sanofi-aventis, and currently, GSK
![Page 3: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/3.jpg)
The Development of CAD
CADMovies\PLAQUED.AVI CADMovies\GLAGOV.AVI
![Page 4: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/4.jpg)
LumenArea
EEM Area
Atheroma Area
Ultrasound Determination of Atheroma AreaPrecise Planimetry of EEM and Lumen Borders
with Calculation of Atheroma Cross-sectional Area
ASTEROID Study
![Page 5: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/5.jpg)
BaselineIVUSExam
Follow-upIVUS
24 monthsrosuvastatin
Atheroma Area10.16 mm2
Lumen Area6.16 mm2
Atheroma Area5.81 mm2
Lumen Area5.96 mm2
![Page 6: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/6.jpg)
Work-up For Stable Angina Usually Starts With W/U For Chest Pain
History is still key! No test can simply just give you an answer… Keep in mind that you may eventually face a
patient with a chest pain syndrome and test findings that are unrelated and chasing the findings is not going to help the symptoms… or the patient
![Page 7: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/7.jpg)
Work-up for Chest Pain
Starts w/ the assessment of symptoms Always take risk factors in the consideration
before doing any tests, look at your goals - what are you doing with the results?
My ultimate benchmark is the COURAGE study – PCI provides symptom relief mainly so if you do not have cardiac sounding symptoms PCI does not do much
However, the diagnosis of CAD could change medical mgmt
![Page 8: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/8.jpg)
The Bayes’ Theorem Pretest probability of CAD, and sensitivity and
specificity of the test => posttest probability of CAD
The patient's clinical information and exercise test results => final estimate
A typical chest pain syndrome in a 50-year-old man or a 60-year-old woman constitutes ~50 % pretest probability
The diagnostic power of EST is maximal when the pretest probability of CAD is 30 to 70%.
![Page 9: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/9.jpg)
Framingham Risk Assessment (Women)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486.
Total Age (years)Cholesterol(mg/dL) 20-39 40-49 50-59 60-69 70-79<160 0 0 0 0 0160-199 4 3 2 1 1200-239 8 6 4 2 1240-279 11 8 5 3 2280 13 10 7 4 2
Cigarette SmokingNonsmoker 0 0 0 0 0Smoker 9 7 4 2 1
AgeYears Points20-34 -735-39 -340-44 045-49 350-54 655-59 860-64 1065-69 1170-74 1475-79 16
CHD RiskPoints 10-y
Risk (%)
<9 <19 1
10 111 112 113 214 215 316 417 518 619 820 1121 1422 1723 2224 27
25 30
Systolic Blood PressureUntreated Treated
<120 0 0120-129 1 3130-139 2 4140-159 3 5160 4 6
HDL-C (mg/dL)Points
>60 -150-59 040-49 1<40 2
Score = 20Risk = 11%
LDL-C goal:<3.5 mmol/L
Ratio: < 5
![Page 10: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/10.jpg)
Therapy of Stable CAD = Vascular Protection +
Symptom Management
![Page 11: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/11.jpg)
ONTARGET Non-Inferiority Comparison
0.8 0.9 1.0 1.1 1.2
RR (95% CI)
Note that the outcomes are presented as point estimates with confidence intervals. The solid lineis the 95% CI representing 1.96 SD and the dashed line is the 97.5% CI representing the adjusted CI for each outcome
Non
-infe
riorit
y M
argi
n
Primary Composite (p = 0.0033)
CV Death / MI / Stroke (HOPE Composite)
(p = 0.0008)
Telmisartan better Ramipril better
ONTARGET
![Page 12: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/12.jpg)
TRANSCEND
• After ONTARGET, TRANSCEND was expected to show HOPE-like results in an ACE-intolerant population of 5926 patients w/ vascular disease
• Pts received telmisartan 80 mg/d vs. placebo• CV Death/MI/Stroke/HHF: 15.7% vs. 17.0% (HR:
0.92; 95% CI 0.81-1.05, p=0.216)• CV death/MI/stroke (HOPE outcome):
13% vs. 14.8% (HR: 0.87; 95% CI 0.76-1.0 p=0.048 unadjusted)
• Adverse events: permanent discontinuation of study medication: 21.6% vs. 23.8% p=0.055
![Page 13: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/13.jpg)
![Page 14: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/14.jpg)
Telmisartan Meta-analysis (CV Death, MI, Stroke, CHF Hosp)
0.7 0.8 0.9 1.0 1.1 1.2
OR (95% CI)
Telmisartan better Placebo better
PROFESS
TRANSCEND
OVERALL
OVERALL <= 6M
OVERALL > 6M
No. events/No. randomized
Telmisartan1367/10146 (13.5%)
466/2954 (15.7%)
1833/13100 (14.0%)
546/13100 (4.2%)
1287/12484 (10.3%)
Placebo1463/10186 (14.4%)
505/2972 (17.0%)
1968/13158 (14.9%)
492/13158 (3.7%)
1476/12575 (11.7%)
p-value
0.067
0.205
0.026
0.075
<0.001
TRANSCEND
![Page 15: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/15.jpg)
Comparison of Event RatesHOPE Endpoint: MI, Stroke or CV Death
P R R T P T
%/yr
1
2
3
4
4.2
3.4 3.34 2.923.02 2.98
∆ = 22%∆ = 13%
![Page 16: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/16.jpg)
How Does Transcend Measure Up?
![Page 17: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/17.jpg)
![Page 18: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/18.jpg)
A Really COURAGEous Trial
2287 patients with stable angina and At least one >80% angioplastiable stenosis (5%) or a positive stress MIBI with at least one >70% and
angioplastiable stenosis (95%) were randomized for aggressive medical therapy + PCI
Sponsored by the VA and CIHR; Pharmaceutical support was channeled through
VA
![Page 19: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/19.jpg)
Medical Therapy
ASA 81-325 mg/d or Plavix if ASA-intolerant Anti-ischemic therapy: LA metoprolol,
amlodipine, isosorbide mononitrate, Lipid-lowering w/ simvastatin + ezetimibe to a
target LDL 1.55-2.2; after this was achieved an attempt was made to raise HDL-levels above 1.0 mmol/l and to lower TG levels to below 1.69 mmol/l
![Page 20: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/20.jpg)
PCI And Outcomes
Complete revascularization was attempted Stenting was the expectation but DES were NA Clinical success: angiographic success + no in-
hospital MI/emergency CABG or death
Primary outcome: Death/MI Secondary outcome: D/MI + stroke and UA Further outcome assessments: QOL, use of
resources, cost-effectiveness
![Page 21: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/21.jpg)
35,539 Pts Screened – 2,287 Included
![Page 22: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/22.jpg)
![Page 23: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/23.jpg)
Results: PCI Group
2/3 of pts had multivessel disease 90% had a positive MIBI, 2/3 several defects PCI was angiographically successful in 93% of
those assigned, clinical success (full revascula-rization and no MI) in 89%
41% received >1 stent (only 31 DES)
![Page 24: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/24.jpg)
Results: Medical Group
Significantly more proximal LAD disease @5 yrs 70% had an LDL<2.2 mmol/l, median
1.84 + 0.03 (baseline: 2.5!) 65% and 94% had a BP<130/85 mmHg 45% of diabetics had a HbA1C<7.0% BMI did not decrease Smokers: 23% - 20% at 5 yrs NS differences between the groups
![Page 25: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/25.jpg)
Outcomes
![Page 26: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/26.jpg)
Outcomes cont’d
Median time to revascularization: 10.0 months vs. 10.8 months
![Page 27: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/27.jpg)
Prevalence of Angina
Angina free patients:PCI Medical therapyBaseline 1 yr 3 yrs 5 yrs Baseline 1 yr 3 yrs 5yrs12% 66 72 74 13 58 67 72NS <0.001 0.02 NS
QOL was better as well – reported at ACC 2007
Subgroups: multivessel disease, prior MI, DM had similar results
![Page 28: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/28.jpg)
Freedom from Angina: COURAGE vs. CASS
12 13
6658
7267
74 72
0
10
20
30
40
50
60
70
80
Baseline 1 Year 3 Year 5 Year
PCI + OMTOMTP
erce
nt
Boden et al. N Engl J Med 2007; 356: 1503-1516.Rogers et al. Circulation 1990;82:1647-1658.
22 22
66
30
63
38
0
10
20
30
40
50
60
70
80
Baseline 1 Year 5 Year
CABGMED
Courtesy of Dr. GBJ Mancini
![Page 29: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/29.jpg)
Discussion - Conclusions Initial aggressive medical management of stable
angina is a good strategy Atherosclerosis is a diffuse disease and opening
up one critical stable stenosis will not change the prognosis (doesn’t tend to cause ACS)
If it fails, PCI is excellent to quickly relieve symptoms but it doesn’t prevent death and MI
Don’t forget that these were stable patients, COURAGE doesn’t apply to ACS patients!
Diff chronic chest pain vs. real stable angina
![Page 30: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/30.jpg)
How Is This Going To Change Our Practice? - Debatable
Even more meticulous risk stratification – ?Ca+ Framingham scores and EST if moderate risk
Maybe in chronic stable angina a cath is not warranted right away – missing the window?
We still need a cath in refractory or ?cases even to rule CAD in or out – CT/MR the future?
At the time of the decision how good the pt’s medical management is – already on max. Rx?
Consent: no benefit re: prevention of MI/D Focus more on the unstable patient
![Page 31: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/31.jpg)
How Has COURAGE Changed My Practice?
I’m not cathing these patients less often But I choose medical Rx more often afterwards I screen even less often for ischemia where it is
not clinically obvious (a-fib, pre-op w/u, atypical CP and few or no risk factors, etc.)
Because if these high risk patients didn’t really benefit for invasive mgmt, asymptomatic pts would benefit even less – although your risk factor mgmt is more aggressive w/ bad CAD
![Page 32: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/32.jpg)
![Page 33: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/33.jpg)
![Page 34: Stable angina core curric.ppt - University of Alberta · 2020. 4. 17. · Stable Angina Stable CAD Gábor Gyenes Core Curriculum Talk October 7, 2011. Disclosure of Conflicts of Interest](https://reader036.vdocument.in/reader036/viewer/2022071508/6128d72bd73ae1040735b1c5/html5/thumbnails/34.jpg)
“God, give me courage to do what I can, humility to
admit what I can't, and wisdom to know the
difference."